SAM #75N98026Q00195

NIH NCATS Solicitation for Dual-Channel Patch-Clamp Amplifier System

The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), is seeking to procure a dual-channel patch-clamp amplifier system to support advanced electrophysiological research on human pluripotent stem cell-derived cell types. - Government Buyer: - Department of Health and Human Services (HHS) - National Institutes of Health (NIH) - National Center for Advancing Translational Sciences (NCATS) - Stem Cell Translation Laboratory (SCTL) - OEMs and Vendors: - MultiClamp 700B (Molecular Devices) is referenced as the benchmark product; brand name or equal solutions are acceptable - Products/Services Requested: - Dual-channel patch-clamp amplifier system (quantity: 1) - Must include: amplifier mainframe, two headstages, control software, calibration tools/model cells, mounting hardware, and electrode holders - Key features: two independent amplifiers, voltage- and current-clamp operation, low-noise capacitive feedback headstages, femtoampere input bias current, capacitance and series resistance compensation, bridge balance, high bandwidth (100 kHz), low RMS noise, integrated control software - Accessories: US and European power cords, USB cable, baseplates for headstage mounting, MultiClamp Commander software CDROM, manual - Unique or Notable Requirements: - System must meet or exceed the salient characteristics of the MultiClamp 700B - Brand name or equal offers accepted; technical equivalence must be demonstrated - Delivery required within 30–60 days after order to avoid delays in ongoing research - Equipment will be used in the Stem Cell Translation Laboratory for high-precision single-cell recordings

Description

The National Center for Advancing Translational Sciences (NCATS) is issuing this combined synopsis/solicitation for a commercial item in accordance with FAR Parts 12 and 13.

The Government requires one (1) dual-channel patch-clamp amplifier system to support high-resolution electrophysiological recordings of human pluripotent stem cell (hPSC)-derived cell types. The system must meet the minimum salient characteristics outlined in the attached Purchase Description.

This requirement is being competed on a brand name or equal basis. Award will be made on a Lowest Price Technically Acceptable (LPTA) basis.

Please refer to the attached Combined Synopsis/Solicitation and Purchase Description for complete details, including submission requirements and evaluation criteria.

View original listing